查找临床试验

已按「冠心病」检索,对应国际通用词 coronary artery disease

试验不在中国怎么办?

共找到 249 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募不适用中国有中心NCT07316452

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

China

年龄 18 Years – 45 Years

Fu Wai Hospital, Beijing, China

正在招募不适用中国有中心NCT06459934

Clinical Outcomes of Cardiovascular Disease

China

年龄 18 Years – 80 Years

Xinjiang Medical University

正在招募不适用中国有中心NCT05829889

Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease

Hong Kong、India、Japan、South Korea、Taiwan

年龄 20 Years – 不限

Seung-Jung Park

正在招募不适用中国有中心NCT05728580

PCI in Beijing Friendship Hospital

China

年龄 18 Years – 不限

Beijing Friendship Hospital

正在招募IV 期中国有中心NCT05410925

Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction

China

年龄 18 Years – 75 Years

The First Affiliated Hospital with Nanjing Medical University

正在招募IV 期中国有中心NCT06013020

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

China

年龄 18 Years – 75 Years

Zunyi Medical College

正在招募IV 期中国有中心NCT06338293

Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

China

年龄 18 Years – 80 Years

Nanjing First Hospital, Nanjing Medical University

正在招募不适用中国有中心NCT06843005

Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease

China

年龄 18 Years – 80 Years

Zhang longjiang,MD

正在招募不适用中国有中心NCT06253962

Carotid Atherosclerosis in Predicting Coronary Artery Disease

China

年龄 14 Years – 90 Years

Shanghai Zhongshan Hospital

正在招募不适用中国有中心NCT07764588

Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

China

年龄 18 Years – 80 Years

Shanghai 10th People's Hospital

正在招募不适用中国有中心NCT04691037

CCTA Improves Clinical Management of Stable Chest Pain

China

年龄 18 Years – 不限

Tianjin Chest Hospital

正在招募不适用中国有中心NCT07587099

Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

China

年龄 18 Years – 不限

Gan Lijun